TMCnet News

Treato Connects Pharma Companies to Hispanic Consumers
[February 25, 2015]

Treato Connects Pharma Companies to Hispanic Consumers


OR YEHUDA, Israel, February 25, 2015 /PRNewswire/ --

Treato's Treato IQ platform now delivers insights from the Hispanic population, providing a new and valuable resource for pharmaceutical companies wishing to engage with the rapidly growing Hispanic community.

The single largest demographic sub-segment of the American population and comprising about 53 million people, the Hispanic community is one with which many organizations wish to engage.

"Discussing personal issues like health is much more comfortable in one's own language, and for the bicultural Hispanic community, this often means sharing online in Spanish," said Ido Hadari, CEO of Treato. "By providing actionable insights from Spanish-language posts on health-related sites, forums and blogs, pharma companies gain understanding of the Hispanic health care consumer, which allows for better health outcomes."

80% of Hispanic Internet users frequent social media sites, according to Pew Research, and Forrester Research writes that Hispanic people in the U.S. are more thn twice as likely as their non-Hispanic counterparts to be content creators and almost twice as likely to write ratings and reviews. 



This new, first-to-market business intelligence offered through Treato IQ allows pharmaceutical companies to understand the unique health experiences of the Hispanic market, enabling them to bring value to this key segment while growing their market share.

About Treato 


Treato™, the leading source of real health insights from millions of real health consumers, uses patented analytics and big data technology to turn billions of disparate online conversations into meaningful social intelligence.  With 2 billion posts analyzed and continuously expanding, Treato is partnered with 12 of the top 50 pharmaceutical companies and is one of the top healthcare consumer sites.  

Treato is privately held with offices in Israel and Princeton, NJ. Investors include Reed Elsevier Ventures, OrbiMed Partners and New Leaf Venture Partners, among others. For more information please visit http://treato.com and corp.treato.com.

Supporting Resources:
Learn more on the Treato blog 
Like Treato on Facebook 
Follow Treato on LinkedIn
Follow Treato on Twitter: @Treato_com

Contact Info:
Ronit Eliav
Manager, Marketing
+972-54-286-6663
[email protected]

SOURCE Treato


[ Back To TMCnet.com's Homepage ]